News & Headlines: Allergy Education and Management

Skin patch to treat peanut allergy shows benefit in children

Wednesday, October 26, 2016  
Share |

A wearable patch that delivers small amounts of peanut protein through the skin shows promise for treating children and young adults with peanut allergy, with greater benefits for younger children, according to one-year results from an ongoing clinical trial. The treatment, called epicutaneous immunotherapy or EPIT, was safe and well-tolerated, and nearly all participants used the skin patch daily as directed.

[READ MORE]


The PTNPA is "The Voice of America's Nut Industry"